Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
30 results
D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma
D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units
D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix
D1.155 - Alterations in B cell memory induced by house dust mite allergen immunotherapy
D1.156 - Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients
D1.157 - Type II Cytokine-Mediated Regulation of Alarmin Receptors in B Cells: Implications for Eosinophilic Esophagitis
D1.159 - The successful resolve of nasal polyps in patient with dupilumab treatment
D2.314 - Late Presentation of Cutaneous Chronic Graft Versus Host Disease – A Case Report
D2.309 - Descriptive Study of Chronic Urticaria Under Treatment with Omalizumab: Our Experience
D2.310 - Dysregulation of barrier function and distribution of nerve cells in a mouse model of atopic dermatitis
D2.311 - Real World Web Survey on the Burden of Urticaria
D2.312 - Impact of metabolic disorders on immune dysregulation in psoriasis and atopic dermatitis
D2.313 - Importance of non-itchy erythema marginatum as a prodromal symptom of hereditary angioedema attacks
D2.315 - Clinical features and Progress of Diagnosis and Therapy of Hereditary Angioedema in China: A Systemic Review of Published Cases
D2.316 - The role of Tumor necrosis factor ligand superfamily member 15 in Atopic dermatitis
D2.317 - The role of sirtuin 2 (SIRT2) in atopic dermatitis
D2.318 - Triggers and prodromal indicators of angioedema attacks in hereditary angioedema patients
D2.319 - Advancing Diagnosis and Management of Hereditary Angioedema in Brazil: Insights from the first 704 patients of a Multicenter Registry
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download